Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinemet versus Stalevo in Parkinson's disease with motor fluctuations
ACTRN12606000046505Phase 4Not yet recruiting
- Sponsor
- Drs. Andrew H. EVANS and Shen Yang LIM
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of levodopa, entacapone and carbidopa in Parkinson's disease (PD) (2 arms), sponsored by Drs. Andrew H. EVANS and Shen Yang LIM. Primary endpoint: Positive Affect and Negative Affect Schedule. Planned start Apr 2006; status: not yet recruiting.
02
Drugs
levodopaentacaponecarbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ACTRN12606000046505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000046505.